“IGeneX reports that its FDA‑cleared single‑step immunoblot tests detect early Lyme disease far more effectively than the conventional system used across the U.S.”
“IGeneX reports that its FDA‑cleared single‑step immunoblot tests detect early Lyme disease far more effectively than the conventional system used across the U.S.”